← Back to Search

Patient Feedback Surveys for Breast Cancer

N/A

Recruiting

Led By Sarah Tevis

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult (18 years of age or more)

Female

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

Study Summary

This trial is measuring how well a new way of reporting cancer treatment results to patients works.

Who is the study for?

This trial is for adult women (18 years or older) who have been diagnosed with breast cancer and are capable of completing surveys on their own. It's not suitable for anyone under 18, men, or patients unable to fill out surveys independently.Check my eligibility

What is being tested?

The study focuses on measuring Patient Reported Outcome Measures (PROMs) in breast cancer patients. Feedback from these PROMs will be shared with both the patients and their healthcare providers to assess how it affects patient engagement, service use, and satisfaction with communication.See study design

What are the potential side effects?

Since this trial involves completing surveys rather than testing a medical intervention like a drug or therapy, there are no direct side effects associated with participating in this research.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am female.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

BREAST Q patient satisfaction with breast surgeon domain

Secondary outcome measures

BREAST Q Patient reported outcome measure survey domains including: Satisfaction with breasts, psychosocial well being, physical well being, sexual well being, and effects of radiation domains.

Currently unmeasured patient reported outcomes using open ended questions

Healthcare utilization including the use of social work services, psycho-oncology services, oncology fitness service, nutrition service, and urgent/emergent services including visits to urgent care or the emergency room.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental GroupExperimental Treatment1 Intervention

Patients will receive the results from the PROM survey in graphical form each time they complete a survey.

Group II: Normative ControlActive Control1 Intervention

These patients will complete the PROM surveys, but will not be presented with the results of the survey.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,748 Previous Clinical Trials

2,163,596 Total Patients Enrolled

28 Trials studying Breast Cancer

6,499 Patients Enrolled for Breast Cancer

National Cancer Institute (NCI)NIH

13,704 Previous Clinical Trials

40,931,072 Total Patients Enrolled

941 Trials studying Breast Cancer

1,543,596 Patients Enrolled for Breast Cancer

Sarah TevisPrincipal InvestigatorUniversity of Colorado, Denver

4 Previous Clinical Trials

475 Total Patients Enrolled

4 Trials studying Breast Cancer

475 Patients Enrolled for Breast Cancer

Media Library

Patient Reported Outcome Measure Survey result feedback Clinical Trial Eligibility Overview. Trial Name: NCT03995082 — N/A

Breast Cancer Research Study Groups: Experimental Group, Normative Control

Breast Cancer Clinical Trial 2023: Patient Reported Outcome Measure Survey result feedback Highlights & Side Effects. Trial Name: NCT03995082 — N/A

Patient Reported Outcome Measure Survey result feedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT03995082 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent are participants engaging in this experiment?

"Affirmative, the clinicaltrials.gov database reveals that this research is actively enlisting participants. Originally posted on October 30th 2019, this trial seeks 370 individuals from 3 distinct medical centers for enrollment."

Answered by AI

Are there any current openings to join this experiment?

"Affirmative. The clinical trial information found on clinicaltrials.gov verifies that the study is currently recruiting volunteers, having been initially posted on October 30th 2019 and last modified August 22nd 2022. A total of 370 participants are needed at 3 different sites for this experiment to be successful."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey

2019. "Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03995082.